Addressing these challenges necessitates a deeper understanding of the mechanistic aspects of TfR-mediated transport, in order to refine existing strategies and enhance the effectiveness of TfR-targeted drug delivery for neurological disorders [116]. This evidence concerns the gene TFRC and nervous system disorder.